Monika van Zonneveld

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk et al. · The Lancet · 2005 · 1.2K citations

Hepatology, Interferon Alfa-2b Alone, Viral Hepatitis +6

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

Monika van Zonneveld, Pieter Honkoop, Bettina E. Hansen et al. · Hepatology · 2004 · 324 citations · Full text

Liver Fibrosis, Immunology, Hepatitis B +19

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

Monika van Zonneveld, A.B. van Nunen, Hubert G.M. Niesters et al. · Journal of Viral Hepatitis · 2003 · 290 citations

Immunology, Hepatitis B, Perinatal Transmission +16

Treatment with Peg-Interferon alpha-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype

Hajo J. Flink, Monika van Zonneveld, Bettina E. Hansen et al. · The American Journal of Gastroenterology · 2006 · 260 citations

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

Monika van Zonneveld, Hajo J. Flink, Elke Verhey et al. · Alimentary Pharmacology & Therapeutics · 2005 · 79 citations · Full text